Sagittal abdominal diameter may effectively predict future complications and increased mortality in intensive care unit patients with severe sepsis

Journal of Critical Care

Volumn 28, Issue 6, 2013, Pages 964-969

  Chalkias, Athanasios ^a   Nitsotolis, Thomas ^a   Papalexandrou, Alexia ^a   Mikros, Sotiris ^a   Iacovidou, Nicoletta ^a   Xanthos, Theodoros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Intensive care; Morbidity; Mortality; Sagittal abdominal diameter; Severe sepsis

Indexed keywords

ADULT; ADVERSE OUTCOME; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASSISTED VENTILATION; BODY MASS; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE; INTRAABDOMINAL FAT; LENGTH OF STAY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; SAGITTAL ABDOMINAL DIAMETER; SEPSIS; SEPTIC SHOCK; TREATMENT DURATION;

INTENSIVE CARE; MORBIDITY; MORTALITY; SAGITTAL ABDOMINAL DIAMETER; SEVERE SEPSIS;

APACHE; BODY MASS INDEX; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SAGITTAL ABDOMINAL DIAMETER; SEPSIS;

EID: 84887402906     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.06.022     Document Type: Article

References (44)

1. Levy M.M., Artigas A., Phillips G.S., et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012, 12:919-924.
2. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
3. Wozniak S.E., Gee L.L., Wachtel M.S., et al. Adipose tissue: the new endocrine organ? a review article. Dig Dis Sci 2009, 54:1847-1856.
4. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
5. Pajvani U.B., Trujillo M.E., Combs T.P., et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 2005, 11:797-803.
6. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
7. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
8. Paolini J.B., Mancini J., Genestal M., et al. Predictive value of abdominal obesity vs. body mass index for determining risk of intensive care unit mortality. Crit Care Med 2010, 38:1308-1314.
9. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
10. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
11. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011, 17:153-159.
12. Empana J.P., Ducimetiere P., Charles M.A., et al. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men: the Paris Prospective Study I. Circulation 2004, 110:2781-2785.
13. Risérus U., de Faire U., Berglund L., et al. Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. J Obes 2010, pii:757939.
14. Harrisson D.A., Welch C.A., Eddleston J.M. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 2006, 10:R42.
15. Schelbert K.B. Comorbidities of obesity. Prim Care 2009, 36:271-285.
16. Singer G., Stokes K.Y., Terao S., et al. Sepsis-induced intestinal microvascular and inflammatory responses in obese mice. Shock 2009, 31:275-279.
17. Cani P.D., Amar J., Iglesias M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
18. Cani P.D., Bibiloni R., Knauf C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
19. Frazier T.H., DiBaise J.K., McClain C.J. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr 2011, 35:14S-20S.
20. Vachharajani V. Influence of obesity on sepsis. Pathophysiology 2008, 15:123-134.
21. Seidell J.C., Andres R., Sorkin J.D., et al. The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord 1994, 18:61-67.
22. Empana J.P., Duciemetiere P., Balkau B., et al. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. Eur Heart J 2007, 28:1149-1154.
23. Anzueto A., Frutos-Vivar F., Esteban A., et al. Influence of body mass index on outcome of the mechanically ventilated patients. Thorax 2011, 66:66-73.
24. Westerly B.D., Dabbagh O. Morbidity and mortality characteristics of morbidly obese patients admitted to hospital and intensive care units. J Crit Care 2011, 26:180-185.
25. Akinnusi M.E., Pineda L.A., El Solh A.A. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36:151-158.
26. Sakr Y., Madl C., Filipescu D., et al. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med 2008, 34:1999-2009.
27. Hutagalung R., Marques J., Kobylka K., et al. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 2011, 37:1793-1799.
28. Wurzinger B., Dünser M.W., Wohlmuth C., et al. The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin Wochenschr 2010, 122:31-36.
29. Smith R.L., Chong T.W., Hedrick T.L., et al. Does body mass index affect infection-related outcomes in the intensive care unit?. Surg Infect (Larchmt) 2007, 8:581-588.
30. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1988, 22:1145-1158.
31. Falagas M.E., Kompoti M. Obesity and infection. Lancet Infect Dis 2006, 6:438-446.
32. Levy B.I., Schiffrin E.L., Mourad J.J., et al. Impaired tissue perfusion: A pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008, 118:968-976.
33. Jonk A.M., Houben A.J., de Jongh R.T., et al. Microvascular dysfunction in obesity: A potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007, 22:252-260.
34. Moon Y.S., Kim D.H., Song D.K. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004, 53:863-867.
35. Pouliot M.C., Després J.P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994, 73:460-468.
36. Öhrvall M., Berglund L., Vessby B. Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes 2000, 24:497-501.
37. Simon L., Gauvin F., Amre D.K., et al. Serum procalcitonin and C- reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
38. Jones A.E., Fiechtl J.F., Brown M.D., et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50:34-41.
39. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
40. Yim J.Y., Kim D., Lim S.H., et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care 2010, 33:2665-2670.
41. Stokić E., Brtka V., Srdić B. The synthesis of the rough set model for the better applicability of sagittal abdominal diameter in identifying high risk patients. Comput Biol Med 2010, 40:786-790.
42. Cándido A.P., Alosta J.P., Oliveira C.T., et al. Anthropometric methods for obesity screening in schoolchildren: the Ouro Preto Study. Nutr Hosp 2012, 27:146-153.
43. Zoccali C., Torino C., Tripepi G., et al. Assessment of obesity in chronic kidney disease: what is the best measure?. Curr Opin Nephrol Hypertens 2012, 21:641-646.
44. Han T.S., Sattar N., Lean M. ABC of obesity. Assessment of obesity and its clinical implications. BMJ 2006, 333:695-698.